Engineering efflux pumps in Azospirillum brasilense to improve sesquiterpenoid production
Implementing Organization
Central Institute of Medicinal and Aromatic Plants (CIMAP)
Principal Investigator
Dr. Mukti Nath Mishra
Central Institute of Medicinal and Aromatic Plants (CIMAP)
Project Overview
The study focuses on the engineering of heterologous sesquiterpenoid production in bacterial systems, but the main challenge is the intracellular accumulation of non-native sesquiterpinoids to toxic levels due to insufficient extracellular transport. Despite attempts to address this issue by expressing native or heterologous efflux pumps in E. coli, no sesquiterpenoid-specific native efflux pumps have been identified in either E. coli or new potential bacterial systems. Azospirillum brasilense, which has an endogenous high-flux isoprenoid pathway, has been engineered to improve the flux, producing more than 2 g/L carotenoids. However, this system only produces 40 mg/L α-humulene and 65 mg/L valencene, which is less than 5% of the carotenoid yield. This suggests that over 95% of the isopreprenoid flux is still available, which can be utilized to improve yields. The study proposes engineering the extracellular transport of sesquiterpenoids in A. brasilense to improve yields by using α-humulene and valencene as model compounds. The main focus will be on transcriptome-based identification of sesquiterpenoid-induced endogenous efflux pumps and optimizing their expression to improve the extracellular transport of non-native sesquiterpenoids.